Holen Sie sich die Stockscreener-App
1.535
1.89%
-0.055
Schlusskurs vom Vortag:
$1.59
Offen:
$1.6
24-Stunden-Volumen:
493.01K
Relative Volume:
1.14
Marktkapitalisierung:
$3.85M
Einnahmen:
$1.03M
Nettoeinkommen (Verlust:
$-11.10M
KGV:
-0.0232
EPS:
-66.0832
Netto-Cashflow:
$-8.21M
1W Leistung:
+4.70%
1M Leistung:
-29.73%
6M Leistung:
-82.97%
1J Leistung:
-97.99%
1-Tages-Spanne:
$1.48
$1.60
1-Wochen-Bereich:
$1.48
$1.94
52-Wochen-Spanne:
$1.40
$103.20
Ispecimen Inc Stock (ISPC) Company Profile
Firmenname
Ispecimen Inc
Sektor
Branche
Telefon
781-301-6700
Adresse
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, NTRA, IQV, IDXX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
1.53 | 4.00M | 1.03M | -11.10M | -8.21M | -66.08 |
TMO
Thermo Fisher Scientific Inc
|
604.92 | 222.97B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
204.22 | 144.27B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
326.85 | 46.72B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
255.41 | 42.67B | 16.63B | 1.39B | 2.12B | 8.0674 |
IDXX
Idexx Laboratories Inc
|
519.80 | 40.98B | 4.45B | 1.10B | 1.06B | 13.59 |
Ispecimen Inc Aktie (ISPC) Neueste Nachrichten
ISPC Stock Holds Ground As iSpecimen Delivers Cancer Research Milestone - timothysykes.com
ISPC Stock Draws Attention After Major Cancer Research Win - StocksToTrade
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
ISPC Stock Draws Traders As Cancer Order Highlights Global Reach - timothysykes.com
ISPC Stock Draws Traders After Rapid Cancer Project Win - StocksToTrade
Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket - Benzinga
ISPECIMENDEAL VALUED AT $4.50 MLN: $2 MLN CASH, $2.50 MLN IN COMMON STOCKSEC FILING - Moomoo
Ispecimen Stock Price Forecast. Should You Buy ISPC? - StockInvest.us
iSpecimen to Acquire AI Assets from Foldlab AI for $4.5 Million - Minichart
iSpecimen to Acquire Foldlab AI Disease Analytics - TipRanks
iSpecimen (NASDAQ: ISPC) lines up reverse split and financings at up to an 80% discount - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
iSpecimen Enters Asset Purchase Agreement With FoldLab AI On September 4 - TradingView
iSpecimen to Acquire Foldlab AI Assets for $4.5 Million, Stock in 5-Year Escrow - TradingView
iSpecimen announces special shareholder meeting - Bitget
ISpecimen Inc. entered into an asset purchase agreement to acquire certain artificial intelligence software, intellectual property and related assets of Foldlab AI Ltd from Foldlab AI Ltd. for $4.5 million. - marketscreener.com
iSpecimen (ISPC) Earnings Update: The EPS Result Is Below Expectation in the Latest Session; Trading Move - vinanet.vn
iSpecimen (ISPC) Earnings Snapshot: The Available Earnings Metric Delivers a Miss under the Current Snapshot; Post-Report: Shares Finish 4.62% Down in the Latest ReadingBalance Sheet Strength - vinanet.vn
iSpecimen completes cancer research project in three weeks By Investing.com - Investing.com Nigeria
iSpecimen completes cancer research project in three weeks - Investing.com
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks - The Manila Times
iSpecimen Delivers Hundreds of International Cancer Blood Specimens Within Three Weeks, Highlighting Biospecimen Network Capabilities - kalkine.ca
ISPC Stock Quote Price and Forecast - CNN
iSpecimen (ISPC) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session - dars.gov.et
iSpecimen (ISPC) Close in Focus: Gains 8.84% to Reach $2.34; Price Context: the Supplied Trading Band Runs From $2.22 to $2.46 in the Available RecordLong Term Entry Picks - vinanet.vn
iSpecimen Inc. (ISPC) Pulls Back 2.81% to $2.25 as Traders Eye Key Support ZoneCall Dominated - vinanet.vn
iSpecimen Inc. (ISPC) Slips 2.81% as Shares Test Key Technical LevelsPrice Momentum Stocks - dars.gov.et
iSpecimen Flags Going Concern Doubt After Q2 Revenue Falls 79% - Minichart
iSpecimen Pays $2 Million for Three-Month Marketing Agreement - Minichart
iSpecimen Engages IR Agency for Investor Marketing - TipRanks
iSpecimen (ISPC) revenue drops to $308K as losses deepen and cash burns - Stock Titan
iSpecimen | 10-Q: Q2 2026 Earnings Report - Moomoo
ISpecimen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Form 8K iSpecimen Inc For: 11 August By Investing.com - Investing.com India
iSpecimen settles arbitration with WestPark Capital for $97,500, ends agreements - Investing.com South Africa
IspecimenEnters Settlement Agreement With Westpark Capital On August 6, 2026 - TradingView
iSpecimen Settles Arbitration and Terminates WestPark Agreements - TipRanks
E.F. Hutton & Co. Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen - The Manila Times
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times
E.F. Hutton serves as placement agent for iSpecimen $5M offering By Investing.com - Investing.com India
E.F. Hutton serves as agent for iSpecimen $5M offering By Investing.com - Investing.com UK
iSpecimen Inc. Prices $5 Million Public Offering of Common Stock and Pre-Funded Warrants to Fuel Growth and Innovation – Minichart - Minichart
iSpecimen Inc (ISPC) Stock News Today - TradingKey
iSpecimen Inc (ISPC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
E.F. Hutton serves as placement agent for iSpecimen $5M offering - Investing.com Nigeria
iSpecimen Completes $5 Million Public Offering - TipRanks
ISpecimen Closes $5 Million Public Offering of Common Stock, Warrants - marketscreener.com
iSpecimen Inc. Closes $5 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded ... - Caledonian Record
E.F. Hutton serves as agent for iSpecimen $5M offering - Investing.com
E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen - The Manila Times
Finanzdaten der Ispecimen Inc-Aktie (ISPC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.69%
2.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):